Thermo Fisher Scientific | TMO - Debt


Thermo Fisher Scientific reported $43.16B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Agilent USD 3.35B 0 Dec/2025
Becton, Dickinson and Co. USD 17.28B 2.26B Mar/2026
Bio Techne USD 200M 60M Mar/2026
Bio-Rad Laboratories USD 1.38B 7.9M Mar/2026
Boston Scientific USD 11.03B 407M Mar/2026
Bruker USD 1.67B 371.6M Mar/2026
Charles River Laboratories USD 3.06B 485.84M Mar/2026
Danaher USD 26.56B 8.07B Jun/2026
Dentsply International USD 2.33B 137M Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
General Electric Aerospace USD 19.16B 1.12B Jun/2026
Henry Schein USD 3.75B 313M Mar/2026
Illumina USD 2.54B 9M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 16.24B 408M Jun/2026
Laboratory Of America USD 7.24B 714.6M Mar/2026
Medtronic USD 28.07B 1.03B Dec/2025
Mettler Toledo International USD 2.23B 76.47M Mar/2026
Myriad Genetics USD 59.3M 19.7M Mar/2025
Olympus JPY 233.87B 4.77B Sep/2025
OraSure Technologies USD 782K 465K Jun/2024
Quest Diagnostics USD 6.41B 179M Mar/2026
Repligen USD 690.94M 144.36M Jun/2026
Revvity USD 3.35B 48.03M Mar/2026
Stryker USD 14.19B 32M Jun/2026
Thermo Fisher Scientific USD 43.16B 3.78B Mar/2026
Veracyte USD 39.33M 321K Mar/2026
Waters USD 5.57B 4.08B Mar/2026
Zimmer Biomet Holdings USD 7.48B 8M Jun/2026